Stereotaxis (STXS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.01, -3.81% vs the prior close of $1.05.
- Volume 870.03K shares, 1.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
STXS slides 3.8% to $1.01, a 52-week low, 4 down days in a row. Closed at $1.01, -3.81% vs the prior close of $1.05. Day range $1.00–$1.07, opened at $1.06.
STXS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — STXS slides 3.8% to $1.01, a 52-week low, 4 down days in a row
- Closed at $1.01, -3.81% vs the prior close of $1.05. Day range $1.00–$1.07, opened at $1.06.
- Volume was 870.03K shares, 1.6x its 50-day average of 556.30K.
- Price is -22.6% vs its 50-day average ($1.30) and -43.5% vs its 200-day average ($1.79).
- 52-week range $1.00–$3.19; today's close sits at 0% of that range, 68.3% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — STXS ends flat (+0.0%) to $1.05, 3 down days in a row
- Closed at $1.05, +0.00% vs the prior close of $1.05. Day range $1.02–$1.06, opened at $1.04.
- Volume was 640.20K shares, 1.2x its 50-day average of 554.03K.
- Price is -19.9% vs its 50-day average ($1.31) and -41.4% vs its 200-day average ($1.79).
- 52-week range $1.02–$3.20; today's close sits at 1% of that range, 67.2% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — STXS dips 0.9% to $1.05, a 52-week low
- Closed at $1.05, -0.94% vs the prior close of $1.06. Day range $1.03–$1.05, opened at $1.04.
- Volume was 692.20K shares, 1.2x its 50-day average of 565.36K.
- Price is -20.3% vs its 50-day average ($1.32) and -41.6% vs its 200-day average ($1.80).
- 52-week range $1.03–$3.20; today's close sits at 1% of that range, 67.2% below the 52-week high.
Oct 13, 2026 — STXS slides 7.0% to $1.06, a 52-week low
- Closed at $1.06, -7.02% vs the prior close of $1.14. Day range $1.05–$1.14, opened at $1.13.
- Volume was 964.50K shares, 1.7x its 50-day average of 566.19K.
- Price is -20.0% vs its 50-day average ($1.33) and -41.3% vs its 200-day average ($1.81).
- 52-week range $1.05–$3.20; today's close sits at 0% of that range, 66.9% below the 52-week high.
Oct 12, 2026 — STXS rises 2.7% to $1.14
- Closed at $1.14, +2.70% vs the prior close of $1.11. Day range $1.08–$1.16, opened at $1.11.
- Volume was 460.60K shares, 0.8x its 50-day average of 571.37K.
- Price is -14.4% vs its 50-day average ($1.33) and -37.1% vs its 200-day average ($1.81).
- 52-week range $1.08–$3.42; today's close sits at 3% of that range, 66.7% below the 52-week high.
Oct 9, 2026 — STXS ends flat (+0.0%) to $1.11, 10 down days in a row
- Closed at $1.11, +0.00% vs the prior close of $1.11. Day range $1.09–$1.12, opened at $1.11.
- Volume was 412.40K shares, 0.7x its 50-day average of 572.30K.
- Price is -16.8% vs its 50-day average ($1.33) and -39.0% vs its 200-day average ($1.82).
- 52-week range $1.09–$3.59; today's close sits at 1% of that range, 69.1% below the 52-week high.
- That makes 10 straight losses.
Oct 8, 2026 — STXS dips 1.8% to $1.11, a 52-week low, 9 down days in a row
- Closed at $1.11, -1.77% vs the prior close of $1.13. Day range $1.09–$1.13, opened at $1.12.
- Volume was 560.30K shares, 1.0x its 50-day average of 574.26K.
- Price is -17.0% vs its 50-day average ($1.34) and -39.2% vs its 200-day average ($1.83).
- 52-week range $1.09–$3.59; today's close sits at 1% of that range, 69.1% below the 52-week high.
- That makes 9 straight losses.
Oct 7, 2026 — STXS dips 1.7% to $1.13, a 52-week low, 8 down days in a row
- Closed at $1.13, -1.74% vs the prior close of $1.15. Day range $1.12–$1.15, opened at $1.13.
- Volume was 337.50K shares, 0.6x its 50-day average of 596.67K — lighter than usual.
- Price is -15.8% vs its 50-day average ($1.34) and -38.3% vs its 200-day average ($1.83).
- 52-week range $1.12–$3.59; today's close sits at 0% of that range, 68.5% below the 52-week high.
- That makes 8 straight losses.
Oct 6, 2026 — STXS dips 2.5% to $1.15, a 52-week low, 7 down days in a row
- Closed at $1.15, -2.54% vs the prior close of $1.18. Day range $1.13–$1.21, opened at $1.18.
- Volume was 873.40K shares, 1.4x its 50-day average of 604.18K.
- Price is -14.5% vs its 50-day average ($1.35) and -37.5% vs its 200-day average ($1.84).
- 52-week range $1.13–$3.59; today's close sits at 1% of that range, 68.0% below the 52-week high.
- That makes 7 straight losses.
Oct 5, 2026 — STXS ends flat (+0.0%) to $1.18, 6 down days in a row
- Closed at $1.18, +0.00% vs the prior close of $1.18. Day range $1.17–$1.20, opened at $1.18.
- Volume was 505.10K shares, 0.8x its 50-day average of 620.17K.
- Price is -12.5% vs its 50-day average ($1.35) and -36.0% vs its 200-day average ($1.84).
- 52-week range $1.17–$3.59; today's close sits at 0% of that range, 67.1% below the 52-week high.
- That makes 6 straight losses.
Oct 2, 2026 — STXS dips 1.7% to $1.18, a 52-week low, 5 down days in a row
- Closed at $1.18, -1.67% vs the prior close of $1.20. Day range $1.18–$1.22, opened at $1.22.
- Volume was 343.80K shares, 0.5x its 50-day average of 643.70K — lighter than usual.
- Price is -12.6% vs its 50-day average ($1.35) and -36.2% vs its 200-day average ($1.85).
- 52-week range $1.18–$3.59; today's close sits at 0% of that range, 67.1% below the 52-week high.
- That makes 5 straight losses.
STXS latest news & SEC filings
Every SEC filing by or about STXS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 19, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 13, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 13, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 13, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $7.67M (prior year $8.80M) (-12.8% vs Jun 30, 2025)
- Net income: -$4.47M (prior year -$3.83M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.05 (prior year -$0.05) ( vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 15, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 15, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade STXS
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 9, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.20% (largest 7.0%).
- Liquidity: about 547.34K shares (≈$552.81K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.01 vs a range of $1.00–$3.19 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Paul J Isaac bought 10,000 shares on Nov 17, 2025.
- Latest filings: 10-Q Aug 12, 2026; 8-K Aug 11, 2026; 8-K Jul 16, 2026.
- Share count: 100.20M shares outstanding (Jul 31, 2026), +10.5% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Electromedical & Electrotherapeutic Apparatus.
STXS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.06 | 1.07 | 1.00 | 1.01 | 870.03K |
| Oct 15, 2026 | 1.04 | 1.06 | 1.02 | 1.05 | 640.20K |
| Oct 14, 2026 | 1.04 | 1.05 | 1.03 | 1.05 | 692.20K |
| Oct 13, 2026 | 1.13 | 1.14 | 1.05 | 1.06 | 964.50K |
| Oct 12, 2026 | 1.11 | 1.16 | 1.08 | 1.14 | 460.60K |
| Oct 9, 2026 | 1.11 | 1.12 | 1.09 | 1.11 | 412.40K |
| Oct 8, 2026 | 1.12 | 1.13 | 1.09 | 1.11 | 560.30K |
| Oct 7, 2026 | 1.13 | 1.15 | 1.12 | 1.13 | 337.50K |
| Oct 6, 2026 | 1.18 | 1.21 | 1.13 | 1.15 | 873.40K |
| Oct 5, 2026 | 1.18 | 1.20 | 1.17 | 1.18 | 505.10K |
| Oct 2, 2026 | 1.22 | 1.22 | 1.18 | 1.18 | 343.80K |
| Oct 1, 2026 | 1.23 | 1.24 | 1.18 | 1.20 | 671.50K |
| Sep 30, 2026 | 1.27 | 1.27 | 1.23 | 1.23 | 335.90K |
| Sep 29, 2026 | 1.26 | 1.29 | 1.22 | 1.25 | 710.80K |
| Sep 28, 2026 | 1.30 | 1.32 | 1.25 | 1.26 | 493.10K |
| Sep 25, 2026 | 1.33 | 1.33 | 1.28 | 1.30 | 404.00K |
| Sep 24, 2026 | 1.33 | 1.33 | 1.29 | 1.29 | 350.60K |
| Sep 23, 2026 | 1.40 | 1.40 | 1.32 | 1.32 | 315.50K |
| Sep 22, 2026 | 1.35 | 1.40 | 1.33 | 1.40 | 594.70K |
| Sep 21, 2026 | 1.34 | 1.36 | 1.31 | 1.36 | 410.70K |
About Stereotaxis
Stereotaxis (STXS) is listed on the NYSE and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in ST.LOUIS, MO. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1289340.
STXS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David Benfer | Director | Jul 1, 2026 |
| Myriam Curet | Director | Jul 1, 2026 |
| Nathan Fischel | Director | Jul 1, 2026 |
| Paul J Isaac | See Remarks | Nov 18, 2025 |
| Ross B Levin | Director | Jul 1, 2026 |
| Arun Swarup Menawat | Director | Jul 1, 2026 |
| Nachum Shamir | Director | Jul 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kimberly R. Peery | Chief Financial Officer | Apr 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Nov 17, 2025 | Paul J Isaac | Buy | 10,000 | $2.18 |
| Nov 17, 2025 | Paul J Isaac | Buy | 10,000 | $2.18 |
| Nov 17, 2025 | Paul J Isaac | Buy | 10,000 | $2.18 |
| Nov 17, 2025 | Paul J Isaac | Buy | 10,000 | $2.18 |
| Nov 14, 2025 | Paul J Isaac | Buy | 20,000 | $2.24 |
| Nov 14, 2025 | Paul J Isaac | Buy | 20,000 | $2.24 |
| Nov 14, 2025 | Paul J Isaac | Buy | 20,000 | $2.24 |
| Nov 14, 2025 | Paul J Isaac | Buy | 20,000 | $2.24 |
STXS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $32.38M | $-21.64M | -0.25 | $-13.69M |
| Dec 31, 2024 | $26.92M | $-24.05M | -0.30 | $-8.50M |
| Dec 31, 2023 | $26.77M | $-20.71M | -0.27 | $-9.14M |
| Dec 31, 2022 | $28.15M | $-18.29M | -0.26 | $-8.41M |
| Dec 31, 2021 | $35.02M | $-10.72M | -0.16 | $-2.95M |
Latest balance sheet: total assets $55.58M, total liabilities $38.10M, cash $10.49M (as of Jun 30, 2026).
STXS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $1.46 |
| May 12, 2026 | 8-K Item 2.02 (results) | $1.92 |
| Mar 9, 2026 | 8-K Item 2.02 (results) | $2.07 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $2.43 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $2.19 |
| Jul 17, 2025 | 8-K Item 2.02 (results) | $2.38 |
| May 12, 2025 | 8-K Item 2.02 (results) | $2.07 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $1.94 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $2.26 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Mar 4, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)Integer (ITGR)TransMedics (TMDX)Axogen (AXGN)LivaNova (LIVN)Nexalin Technology (NXL)Conmed (CNMD)Ceribell (CBLL)InMode (INMD)Electromed (ELMD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on STXS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.